About BICO
BICO is a company based in Boston (United States) founded in 2016. BICO has completed 4 acquisitions, including Advanced BioMatrix, Allegro 3D and Biosero. BICO offers products and services including Lab Automation Platform and Instruments. BICO operates in a competitive market with competitors including Nuclera Nucleics, Aspect Biosystems, CELLINK, Collplant and ROKIT Healthcare, among others.
- Headquarter Boston, United States
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bico Group Ab Class B
-
Annual Revenue
$176.79 M (USD)-3.19as on Dec 31, 2024
-
Net Profit
-$498.64 K (USD)99.53as on Dec 31, 2024
-
EBITDA
$9.33 M (USD)185.83as on Dec 31, 2024
-
Latest Funding Round
$48.16 M (USD), Post-IPO
Jan 10, 2023
-
Investors
Sartorius
& 1 more
-
Employee Count
Not available
-
Investments & Acquisitions
Advanced BioMatrix
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BICO
BICO is a publicly listed company on the OMXSTO with ticker symbol BICO in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BICO
BICO offers a comprehensive portfolio of products and services, including Lab Automation Platform and Instruments.
Platform for enabling end-to-end lab automation in life sciences.
Devices for lab processes and scientific research applications.
People of BICO
Unlock access to complete
Funding Insights of BICO
Investors in BICO
BICO has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Sartorius and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Laboratory and biopharmaceutical equipment is developed for production processes.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for BICO
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BICO
BICO has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Advanced BioMatrix, Allegro 3D and Biosero.
Investment portfolio details for BICO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
3D bioprinting is used to develop human tissues and biomaterials.
|
Locked | Locked | 2017 | Locked | |
|
High quality collagen for cell culture, gels, coatings and other research applications and developer of bioinks for 3D printing
|
Locked | Locked | 2008 | Locked | |
|
Software solutions are provided for automating laboratory workflows.
|
Locked | Locked | 2003 | Locked |
Complete acquisition details for BICO
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BICO
Detailed financials for BICO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bico Comparisons
Peer comparison for BICO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BICO
BICO operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, Aspect Biosystems, CELLINK, Collplant and ROKIT Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Desktop bioprinter for genes and proteins production is developed.
|
|
| Locked | Locked | Locked |
Bioprinting technology and tissue therapeutics for regenerative medicine are developed.
|
|
| Locked | Locked | Locked |
3D bioprinters and bioinks are developed for research applications.
|
|
| Locked | Locked | Locked |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| Locked | Locked | Locked |
4D bio-printer solutions for tissue regeneration are provided.
|
|
| Locked | Locked | Locked |
Provider of 3D printing pharmaceutical technology platform for drug design
|
Detailed competitors of BICO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bico
Complete news archive for BICO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BICO
BICO was founded in 2016 and raised its 1st funding round 5 years after it was founded.
BICO is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Annual revenue of BICO is $176.79M as on Dec 31, 2024.
BICO was founded in 2016 and is headquartered in Boston, United States. Operations focus on the life sciences sector, where technologies, products, and services are developed and marketed. Robotics, artificial intelligence, computer science, and 3D bioprinting are utilized to support cell culturing in 3D environments, high-throughput drug screening, and the printing of human tissues and organs. These capabilities serve the medical, pharmaceutical, and cosmetic industries.
BICO's top competitors include Nuclera Nucleics, Aspect Biosystems and Allevi.
BICO offers Lab Automation Platform and Instruments.
Yes, BICO is publicly traded on OMXSTO under the ticker symbol BICO.
BICO has made 4 acquisitions, including Advanced BioMatrix, Allegro 3D, and Biosero.
BICO has 2 investors. Key investors include Sartorius, and European Union.
The ticker symbol of BICO is BICO on OMXSTO.